A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels
Clinical trial NCT01770743 · COMPLETED
Trial details
- NCT number
- NCT01770743
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-02-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.